GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 116 filers reported holding GOSSAMER BIO INC in Q2 2021. The put-call ratio across all filers is 7.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $29,504 | -80.6% | 23,416 | -66.6% | 0.00% | – |
| Q4 2022 | $151,952 | -81.7% | 70,024 | +1.1% | 0.00% | -100.0% |
| Q3 2022 | $830,000 | +49.3% | 69,248 | +4.3% | 0.00% | 0.0% |
| Q2 2022 | $556,000 | -7.5% | 66,376 | -4.2% | 0.00% | 0.0% |
| Q1 2022 | $601,000 | -29.9% | 69,290 | -8.6% | 0.00% | 0.0% |
| Q4 2021 | $857,000 | -7.9% | 75,805 | +2.3% | 0.00% | 0.0% |
| Q3 2021 | $931,000 | +33.6% | 74,092 | -13.7% | 0.00% | 0.0% |
| Q2 2021 | $697,000 | -11.8% | 85,823 | +0.4% | 0.00% | 0.0% |
| Q1 2021 | $790,000 | -4.7% | 85,439 | -0.4% | 0.00% | 0.0% |
| Q4 2020 | $829,000 | -22.1% | 85,747 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $1,064,000 | +9.5% | 85,747 | +14.7% | 0.00% | 0.0% |
| Q2 2020 | $972,000 | +45.3% | 74,747 | +13.4% | 0.00% | +100.0% |
| Q1 2020 | $669,000 | -34.3% | 65,912 | +1.2% | 0.00% | -50.0% |
| Q4 2019 | $1,018,000 | -9.3% | 65,149 | -2.5% | 0.00% | 0.0% |
| Q3 2019 | $1,122,000 | +64.3% | 66,823 | +116.9% | 0.00% | +100.0% |
| Q2 2019 | $683,000 | +83.1% | 30,802 | +79.1% | 0.00% | 0.0% |
| Q1 2019 | $373,000 | – | 17,201 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
| Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
| Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
| Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
| Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
| HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
| Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
| Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
| ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
| EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |